bioRxivNeurosciencePreprint
Neurotrauma-induced vulnerability of C9orf72 ALS iPSC-motor neurons revealed by biofidelic stretch injury
Eric J. Martin, Catrina Reyes, Angela MitevskaiD, Citlally Santacruz, Francesco AlessandriniiD, Ian E. Jones, Gopinath KrishnaniD, Gerard EsteruelasiD, Fen‐Biao GaoiD, John D. FinaniD, Evangelos KiskinisiD
- Citations
- 5
Abstract
A hexanucleotide repeat expansion (HRE) in C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, patients with the HRE exhibit a wide disparity in clinical presentation and age of symptom onset suggesting an interplay between genetic background and environmental stressors. Neurotrauma, resulting from traumatic brain or spinal cord injury has been shown to increase the risk of ALS in epidemiological studies. Here, we combine patient-specific induced pluripotent stem cells (iPSCs) with a custom-built device to deliver biofidelic stretch trauma to C9orf72 patient and isogenic control motor neurons (MNs) in vitro. We find that mutant but not control MNs exhibit selective degeneration after a single incident of severe trauma, which can be partially rescued by pretreatment with a C9orf72 antisense oligonucleotide. A single incident of mild trauma does not cause degeneration but leads to cytoplasmic accumulation of TDP-43 in C9orf72 MNs. This mislocalization, which only occurs briefly in isogenic controls, is eventually restored in C9orf72 MNs after 6 days. Lastly, repeated mild trauma ablates the ability of patient MNs to recover. These findings highlight alterations in TDP-43 dynamics in C9orf72 ALS patient MNs following traumatic injury and demonstrate that neurotrauma compounds neuropathology in C9orf72 ALS. More broadly, our work establishes an in vitro platform that can be used to interrogate the mechanistic interactions between ALS and neurotrauma.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NEK1 haploinsufficiency worsens DNA damage but not defective ciliogenesis in C9ORF72 patient-derived iPSC-motoneurons
Serena Santangelo, Sabrina Invernizzi, … Antonia Ratti·Human Molecular GeneticsPeer-reviewed·Sep 2, 2024
- Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair
Nidaa A. Ababneh, Jakub Scaber, … Kevin Talbot·Human Molecular GeneticsPeer-reviewed·Jun 1, 2020
- CRISPR/Cas9-mediated generation of a de novo C9ORF72 knock-in isogenic iPSC cell bank to model ALS and FTD
Niamh Louise O’Brien, Erin C. Hedges, … Sarah Mizielinska·bioRxiv·Nov 12, 2025
- Generation of C9orf72 repeat knock-in iPSC lines for modelling ALS and FTD
Rachel Coneys, Alexander J. Cammack, … Adrian M. Isaacs·bioRxiv·Feb 10, 2025
- Dysregulated expression of inflammasome and extracellular matrix genes in C9orf72-ALS/FTD microglia
Nisha S. Pulimood, Louise Thiry, … Stefano Stifani·bioRxiv·Feb 13, 2025
- Inflammasome mediated neuronal-microglial crosstalk: a therapeutic substrate for the familial C9orf72 variant of the frontotemporal dementia/amyotrophic lateral sclerosis
Kyle J. Trageser, Chad Smith, … Giulio Maria Pasinetti·bioRxiv·Jan 27, 2022